Drugs from bugs tops list of LAB282’s first round of grants
LAB282, the £13m drug discovery partnership for Oxford University, has made its first wave of awards, backing projects targeting cardiovascular and infectious diseases. Launched last year as a partnership between the University, Evotec and Oxford Sciences Innovation, LAB282 aids the rapid translation of research outputs into new drug discovery and development programmes. It draws on […]